We would love to hear your thoughts about our site and services, please take our survey here.
LUCY partner with New Look Vision group, in Canada;
https://tinyurl.com/mry6jp6c
They really going for it!
It isn't all about "tinpot",
A fully funded regulatory environment, a streamlined clinical trial process, higher tax incentives for research and European cooperation would all lead to better outcomes for patients.
Boris made a big speech promising change but this Government has delivered nothing.
Enough from me about politics.....back to waiting, as ever. π
My point being, (before LSE crashed);
A change of Government, with full MHRA and NHS funding restored and a better European relationship (e.g. Horizon), remains our only hope.
Otherwise companies like Valirx will continue to suffer.
Just pop over to SAR and ask for their opinions of the MHRA!!
Ain't happening Fred,
In June 2021 Boris made a speech about restoring Britain as a scientific superpower, exactly the opposite has occurred.
In Nov 21 Valirx signed an LOI with Theoremrx and promised a "transformative year", exactly the opposite has occurred.
https://tinyurl.com/nhjnvtdj
Agred, Lucyd safety glasses must have multiple applications within industry.
Lucy have a strong patent portfolio, Reebok launching shortly, Armor glasses coming and Micah Richards signing.
If Q1 2024 sales figures show a similar improvement to Q4 2023 then perhaps we'll see a change in sentiment.
Green shoots, maybe.
GLA.
Accessible tactile controls and safety glasses, to be branded Lucyd Armor for launch in mid 2024.
Also; receipt of notices of allowance on three smart eyewear design patent applications (patent application Nos. 29/806,204, 29/806/207, 29/806/209) and expects design patents to issue from these three allowed applications after payment of issue fees.
Question is, can they sell them in sufficient quantities?
Https://tinyurl.com/47fun5c6
2 tranches of $500,000 via a CLN.
Perhaps De Courcey can persuade Cox to update shareholders.
π
We already have three incompetents, namely ; Cox, Lampshire and Treharne.
Bwtween them they've delivered the square root of zero, despite many years of salary, which also makes them very expensive.
Also, we'll probably lose Suzy's scientific expertise
What a disaster.
Personally, I wouldn't issue a partnership RNS without checking the URL links are live.
Perhaps I'm being harsh on TEK, but the dearth of good news and resulting slump in the SP is frustrating.
I'll go for a lie down. π΄
Irritatingly the distributors website is down, on the day the partnership is announced;
https://www.windsoreyes.com/
Can't TEK get anything right?
Raise is for;
" the launch of our new product lines (including, but not limited to, Reebok Powered by Lucyd), investment into distribution channels, and general corporate purposes. See βUse of Proceedsβ.
Also, they've had a 180 day extension to the NASDAQ non compliance rule until 30th July 2024.
(Apologies for the "7" typo in the thread header)
Https://tinyurl.com/ydzujxzv
$1.1 million raise for 3.8 million odd shares @0.29.cents.
Further dilution for TEK, although the stake in LUCY isn't worth much anyway. π
"Star Robotics are a manufacturer of cloud and AI-based multi-utility robots. It offers products for surveillance, industrial inspection, assistance to people with disabilities, and defense markets. It also provides a platform for the management and supervision of robot fleets remotely."
That's a few new applications for Guident that I hadn't considered.
Good news.
Well, various Euda creditors are converting debt into shares;
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318216888&type=HTML&symbol=EUDA&cdn=8bd69302aaac2e77331947ad647cf803&companyName=Euda+Health+Holdings+Limited&formType=6-K&formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&dateFiled=2024-04-04
EUDA have also drawn down the second tranche of cash from Gilandi.
Something is happening behind the scenes, I hope. π
You're right twice Lolly;
It was "Spot on Top(catz)".
Plus, your assumption is correct too - I do indeed value my capital, as does James Kight. π
Let's see what happens in Q2.
Happy Easter. π£ π
Indeed,
I'm still curious as to why the requisition notice was withdrawn and on what terms?
I can only assume we are awaiting Mr De Courcey to pass his regulatory due diligence check before any announcement can be made.
The RNS also states that;
"No serious adverse events have been reported TO DATE". π
Spot on Top!!
RNS - James Kight buying more.
Now let's hope your chart predictions are as good!! π
Keep going πͺ Cobalt.
Sareum were close to going bust, yet still the doomsayers are out in force.
At least we have hope, albeit in last chance saloon.
A Singaporean investor has taken a notifiable stake in EUDA via a holding company.
It would seem its the same Mr Tan Meng Dong who was previously the CEO of EUDA from Nov 21 - Nov 22 and now owns "8i Holdings"
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318189702&type=HTML&symbol=EUDA&cdn=e6d932586e72cf04e9a9e2c6ccf7f33b&companyName=Euda+Health+Holdings+Limited&formType=SC+13G&formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&dateFiled=2024-03-27
Maybe a precursor for the merger, or maybe nothing......!!
Back to waiting, as ever....